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Introduction
 Neutrophils play an important role in host 
defense, but also cause damage to host tissue at 
the same time1.  They act at inﬂammatory sites, 
which they reach after targeting and extravasa-
tion from the peripheral blood stream where they 
are normally present.  Upon interaction with 
invading microorganisms or inﬂammatory media-
tors they produce large amounts of toxic oxygen 
radicals (superoxide anion and hydrogen peroxide) 
by activation of the NADPH-oxidase.  Although 
the mechanism by which such activation is 
induced and regulated in vivo remains unclear, 
multiple extracellular mediators have been found 
to activate the neutrophil NADPH-oxidase in 
vitro.  Superoxide generation is a component of 
the mechanism by which neutrophils combat inva-
sive pathogens, but this generation may play a 
pathogenetic role in some inﬂammatory states. 
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Abstract : Biochemical factors of neutrophils in exudates from acute surgical wounds have been 
investigated. However, the fate and functions of neutrophils in the exudates have not been clariﬁed 
and no prior study had compared exudates in the early and late surgical wound stages.  The pur-
pose of this study was to investigate the differing effects of exudates on human neutrophils be-
tween the early and late phases of inﬂammation, and to clarify the factors affecting neutrophil 
function.  Exudates from 30 surgical patients with oral cancer who underwent radical neck dissec-
tion were collected on the 1st and 5th day after surgery (EX1, EX5).  Neutrophils were obtained 
from two healthy volunteers.  Following incubation of the neutrophils with the exudates we exam-
ined superoxide anion production and hAPO-1/Fas expression by the neutrophils, apoptosis of the 
neutrophils and cytokine concentration in the exudates, and the factors related to neutrophil apop-
tosis.  Superoxide anion production by neutrophils incubated with EX1 was signiﬁcantly higher 
than by those incubated with EX5, while hAPO-1/Fas expression by the neutrophils was also sig-
niﬁcantly greater upon incubation with EX5.  The DNA ladder was detected only in human neutro-
phils incubated with EX5.  The level of IL-10 in EX1 was signiﬁcantly lower than that in EX5.  
Apoptosis of the neutrophils incubated with EX5 was suppressed by the addition of anti-IL-10 anti-
body.  These results indicate that neutrophils have their functions augmented and apoptosis is in-
hibited in the early phase of inﬂammation.  Furthermore, IL-10 is involved in apoptosis of neutro-
phils in the late phase of inﬂammation.
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Thus, the functions of neutrophils most likely dif-
fer between the early and late phases of inﬂam-
mation.
 In acute inﬂammation, a signiﬁcant increase in 
the number of neutrophils is observed.  This 
increase appears to be a physiologic and beneﬁcial 
host response, as neutrophils play a key role in 
eliminating invading microorganisms.  However, 
there are many reports that chronic release of 
toxic products may result in severe tissue injury 
at sites of inﬂammation2,3.  Moreover, prolonged 
neutrophil survival during inﬂammation can dam-
age tissues due to the release of these toxic prod-
ucts.  Apoptosis regulates neutrophil efﬁcacy4,5, 
but is inhibited in neutrophils of patients with 
systemic inﬂammatory response syndrome, burns, 
or severe trauma6–9.  Apoptosis represents a physi-
ological clearance mechanism in the circulation 
and tissue of healthy humans10.  In mature human 
neutrophils, this is achieved spontaneously and 
rapidly, within hours.  Several recent reports have 
focused on the fate and function of circulating 
neutrophils in surgical stress6–8,11,12.  Neutrophils 
in exudates of wounds act at the local site, and 
various biochemical factors of neutrophils in exu-
dates from acute surgical wounds have been 
investigated13–15.  However, the fate and functions 
of neutrophils in the exudates from surgical 
wounds have not been clariﬁed and no study prior 
to the present had compared cytokines of exudates 
in the early and late surgical wound stages, 
largely due to the difﬁculty in collecting exudates 
from human minor surgery and animal experi-
ments before ﬁve postoperative days.  In the pres-
ent study, the collection of exudates from patients 
was enabled at one and ﬁve postoperative days. 
To our knowledge this is the ﬁrst study showing 
how exudates affect neutrophils in the early and 
late stages of inﬂammation.
 The purpose of this study was to investigate the 
difference in the effects of inﬂammatory exudates 
on human neutrophils between the early and late 
phases of inﬂammation, and to clarify the factors 
affecting neutrophil function.
Materials
1. Exudates
 Exudates from 30 surgical patients with oral 
cancer who underwent radical neck dissection in 
Hokkaido University Hospital were collected 
through tube drains which were detained in the 
wound sterilely, on the 1st (EX1) and 5th days 
(EX5) after surgery.  Antibiotics were used for the 
patients for one week postoperation.  Chemothera-
peutic agents were not used.  The exudates were 
immediately centrifuged at 1500 r.p.m.  for 10 
minutes to remove cellular debris.  The superna-
tant was removed, aliquoted and stored at –80℃. 
Patients with postoperative infection of wound 
were excluded ; whether the wound of a patient 
was infected was diagnosed clinically.
2. Human neutrophils
 Heparinized venous blood was obtained from 
two healthy volunteers.  Human neutrophils were 
separated from the blood using 6% isotonic sodium 
chloride containing hydroxyethyl starch and cen-
trifugation on Ficoll-HypaqueⓇ (Amersham Phar-
macia Biotech AB, Sweden).  Contaminating red 
blood cells were removed by cold hypotonic water 
lysis.  The neutrophils were suspended in Hanks’ 
balanced salt solution (HBSS) at a concentration 
of 106 cells/ml and cultured at 37℃.
Methods
1. Assay of superoxide anion production by 
neutrophils incubated with exudates
 Human neutrophils were mixed with EX1 or 
EX5 at different concentrations (10%–70%) or 
HBSS (no exudate as control) and then incubated 
at 37℃ for 30, 45 and 60 min.  Production of 
superoxide anion was assayed by measuring the 
superoxide dismutase-inhibiting reduction of 
equine ferricytochrome C using dual wavelength 
spectrophotometry (Hitachi U-1100, Tokyo, 
Japan).  The reaction was initiated by the addition 
of 139 nM phorbol myristate acetate (PMA; 
Sigma, St Louis, Mo, USA)16.
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2.  Scanning electron microscopy observation 
of morphological changes in neutrophils
 Neutrophils were mixed with EX1 (at 50% con-
centration), EX5 (at 50% concentration) or HBSS 
(as control), incubated at 37℃ for 60 min, ﬁxed in 
Karnovskys’ solution (pH 7.4), post-ﬁxed in 0.1 
mol/l cacodylate buffer and 0.1 M osmium acid for 
1 h, dehydrated and then coated with Pt-Pd.  Mor-
phological changes in these neutrophils were 
observed by scanning electron microscopy (SEM: 
Hitachi S-4300, Tokyo, Japan).
3.  Assay of lactate dehydrogenase (LDH) 
released from neutrophils
 The LDH value in each exudate (at 50% concen-
tration) was measured using the Lactate Dehydro-
genase C2-Test (Wako Pure Chemical Industries, 
Osaka, Japan) according to the manufacturer’s 
instructions.  Neutrophils were mixed with EX1 
(at 50% concentration) or EX5 (at 50% concentra-
tion) and then incubated at 37℃ for 60 min.  The 
LDH value of each sample was measured.  The 
difference of the LDH value of each sample and 
each exudate was calculated.
4.  Assay of hAPO-1/Fas expression in EX1 
and EX2
 The amount of hAPO-1/Fas in EX1 and EX2 
was measured using the human APO-1/Fas ELISA 
Kit (Biosource International, California, USA) 
according to the manufacturer’s instructions.
5.  Detection of neutrophil apoptosis
 Neutrophils were mixed with EX1 (at 50% con-
centration) or EX5 (at 50% concentration) and 
incubated at 37℃ for 120 min.  Neutrophil apopto-
sis was detected using the Apoptosis Ladder 
Detection Kit WAKO (Wako, Tokyo, Japan) based 
on the TUNEL assay, according to the manufac-
turer’s instructions.
6.  Assay of cytokines in exudates
 IL-1β, IL-6, IL-8, IL-10, TNF-α, INF-γ, G-CSF 
and GM-CSF in EX1 or EX5 were measured using 
ELISA kits (Endogen, Inc., USA) according to the 
manufacturer’s instructions.
7.  Effect of addition of anti-IL-10 antibody to 
EX5 on neutrophil apoptosis
 Neutrophils were mixed with EX5 (at 50% con-
centration) or EX5 (at 50% concentration) and 
polyclonal anti-IL-10 antibody (40 pg/ml) (Sigma, 
USA) or HBSS and anti-IL-10 antibody (as con-
trol), and incubated at 37℃ for 60 min.  Apoptosis 
of the neutrophils was evaluated using the Apop-
tosis Screening kitⓇ (Wako Pure Chemical Indus-
tries, Osaka, Japan) according to the manufac-
turer’s instructions.
8. Statistical analysis
 Data was analyzed using the Wilcoxon matched-
pair signed-rank test with the level of signiﬁcance 
set at 5%.
9. Ethical considerations
 The protocol of this study was approved by the 
Committee of Ethics at the Graduate School of 
Dental Medicine, Hokkaido University, Japan.
Results
1.  Superoxide anion production by neutro-
phils incubated with exudates
 Fig. 1 shows the quantity of superoxide anion 
produced by human neutrophils mixed with each 
exudate for 30 minutes.  Superoxide anion produc-
tion by neutrophils incubated with EX1 was sig-
niﬁcantly higher than that of neutrophils incu-
bated with EX5 at any concentration except 0%. 
There was no marked difference in the quantity of 
superoxide anion among the different concentra-
tions of EX1 and EX5.
 Fig. 2 shows the quantity of superoxide anion 
produced by human neutrophils mixed with 10％ 
exudates for 30 minutes and 60 minutes.  There 
was no difference in results with time in the quan-
tity of superoxide anion between EX1 and EX5.
2. SEM observation
 Fig. 3 shows the morphology of neutrophils 
observed by SEM.  The surface morphology of neu-
trophils incubated with EX1 was more complex 
than that of the controls.  The surface morphology 
of neutrophils incubated with EX5 is smoothed, 
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Fig. 1 The quantity of superoxide anion produced by human neutrophils incubated with exudates for 30 minutes Superoxide 
anion production by neutrophils incubated with EX1 was signiﬁcantly higher than that of neutrophils incubated with 
EX5 at any concentration except 0％. There was no marked difference in the quantity of superoxide anion among the 
different concentrations of EX1 and EX5.
Fig. 3 Scanning electron micrographs of neutrophils incubated in media containing : (A) HBSS, (B) EX1, and (C) EX5. The 
surface morphology of neutrophils incubated with EX1 was more complex than that of the controls. The surface 
morphology of neutrophils incubated with EX5 was smoother than that of the controls.
(A) (B) (C)
Fig. 2 The quantity of superoxide anion produced by human neutrophils incubated with 10％ exudates. There was no difference 
in results with time in the quantity of superoxide anion between EX1 and EX5.
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and the cell shrinks.  The surface morphology was 
smoother than that of the controls.
3.  Lactate dehydrogenase (LDH) released 
from neutrophils
 Fig. 4 shows the value of LDH in each exudate 
released from neutrophils.  There was no signiﬁ-
cant difference in the level of LDH among HBSS, 
EX1 and EX5.
4. hAPO-1/Fas expression in EX1 and EX2
 Fig. 5 shows the level of hAPO-1/Fas in each 
exudate.  The level of hAPO-1/Fas was signiﬁ-
cantly greater in EX5 than EX1.  There was no 
signiﬁcant difference in the level of hAPO-1/Fas 
between EX1 and HBSS.
5. Detection of neutrophil apoptosis
 The DNA ladder was detected in neutrophils 
incubated with EX5, but not in those incubated 
with EX1 or HBSS (Fig. 6).
6. Cytokines in exudates
 Table 1 shows the released amount of each 
cytokine for each exudate.  There were no signiﬁ-
cant differences in the levels of IL-6, IL-8, INF-γ, 
G-CSF, or GM-CSF between EX1 and EX5.  The 
Fig. 6 Detection of apoptosis of human neutrophils 
incubated with exudates M, DNA marker ; 5, EX5; 
1, EX1
The DNA ladder was detected in neutrophils incubated 
with EX5, but not in those incubated with EX1 or HBSS.
Fig. 4 Assay of lactate dehydrogenase (LDH) released 
from human neutrophils incubated with 
exudates. There was no signiﬁcant difference in 
the level of LDH amang HBSS, EX1, and EX5.
Fig. 5　Assay of hAPO-1/Fas in exudates
The level of hAPO-1/Fas was signiﬁcantly greater in 
EX5 than EX1. There was no signiﬁcant difference in 
the level of hAPO-1/Fas between EX1 and HBSS.
Table 1　Cytokine concentration in exudates
Mean (SD) pg/ml
Cytokine EX1 EX5
IL-1β
IL-6
IL-8
IL-10
TNF-α
INF-γ
G-CSF
GM-CSF
126.5 (140.6)
474.1 ( 55.5)
360.2 (171.3)
21.9 ( 16.7)
34.9 ( 29.6)
41.0 (　3.9)
149.8 (180.2)
5.9 (　3.0)
＊
＊
＊
12.3 ( 18.9)
467.5 (123.4)
351.1 (227.2)
37.5 ( 16.9)
9.8 ( 12.9)
38.8 (　6.7)
134.3 (148.6)
4.3 (　2.7)
＊
＊
＊
＊ Wilcoxon Matched-Pair Signed-Rank Test 
Revealed signiﬁcant differences of cytokine 
concentration between EX1 and EX5 (p＜ .01).
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level of IL-1β and TNF-α in EX1 was signiﬁcantly 
higher than that in EX5.  The level of IL-10 in 
EX1 was signiﬁcantly lower than that in EX5.
7.  Changes in neutrophil apoptosis by the 
addition of anti-IL-10 antibody to EX5
 Fig. 7 shows the appearance of neutrophil apop-
tosis in three groups (Control, EX5, EX5+Anti-
IL10 antibody).  Apoptosis of the neutrophils incu-
bated with EX5 was suppressed by the addition of 
anti-IL-10 antibody.
Discussion
 In this experiment, neutrophils incubated with 
HBSS were mixed with diluted exudates.  How-
ever, the quantity of superoxide anion emitted 
from neutrophils showed no correlation with exu-
date concentration.  Cytokines have a concentra-
tion-dependent character, but it is thought that 
there was no difference in the quantity of superox-
ide anion because the compositions of cytokines in 
dilute exudates were the same.  Therefore, the 
evaluation methods of this study were appropriate 
for examining our hypothesis.
 LDH is an intracellular enzyme involved in the 
glycolytic pathway, and the LDH value increases 
when the cell membrane is destroyed.  In the pres-
ent study, the LDH value did not increase when 
neutrophils were incubated with the exudates, 
indicating that the cell membranes of the neutro-
phils were not destroyed.
 Pseudopodia are observed on the surface of nor-
mal neutrophils by scanning electron microscopy. 
With the development of neutrophil apoptosis, the 
cell surface is smoothed, and the cell shrinks17.  In 
the present study, pseudopodia were observed on 
neutrophils incubated with EX1 and HBSS, while 
the cell surface was smooth in neutrophils incu-
bated with EX5.  In addition, the DNA ladder was 
only detected in neutrophils incubated with EX5. 
Thus, neutrophils incubated with EX1 were acti-
vated and neutrophils incubated with EX5 were 
rapidly induced to apoptosis.  We also found that 
superoxide production was enhanced in neutro-
phils incubated with EX1, but was suppressed in 
neutrophils incubated with EX5.  Neutrophils are 
important cellular mediators of tissue damage 
during inﬂammation and it is believed that this 
control of neutrophils minimizes the potential risk 
of tissue injury related to the release of neutro-
phil-derived toxic mediators.  Conceivably, failure 
of this system could lead to exacerbation of tissue 
injury at sites of inﬂammation.  Jimenez et al. 
reported that a signiﬁcant inverse correlation was 
seen between respiratory burst activity and apop-
totic rates for circulating neutrophils from 
patients with systemic inﬂammatory response 
syndrome.  They described that neutrophil apopto-
sis was exquisitely sensitive to modulation by fac-
tors associated with the expression of an inﬂam-
matory response18,19.  They also suggested that 
inhibition of neutrophil apoptosis is associated 
Fig. 7 Change in human neutrophil apoptosis by addition of 
anti-IL-10 antibody to EX5.
Apoptosis of the neutrophils incubated with EX5 was 
suppressed by the addition of anti-IL-10 antibody.
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with superoxide production by neutrophils.  On 
the other hand, it is thought that resolution of the 
local inﬂammatory process is closely associated 
with increased neutrophil apoptosis.  We believe 
that inhibition of apoptosis of neutrophils aids the 
activation of neutrophils for host defense in early 
inﬂammation, and neutrophils are rapidly induced 
to apoptosis to decrease host damages in late 
inﬂammation.
 Neutrophils may be committed to autocrine 
death resulting from Fas/FasL engagement on the 
cell surface6, and proinﬂammatory cytokines sup-
press Fas-induced apoptosis in normal neutro-
phils20–23.  It is known that apoptosis and activa-
tion of circulating neutrophils from healthy 
individuals are modulated by several factors such 
as cytokines, complement factors, lipopolysaccha-
rides, a low dose of living bacteria, the Fas/Fas 
ligand system, oxidative stress, and adhesion mol-
ecules24–28.  Among these factors, cytokines are 
considered to be the principal modulators of neu-
trophils, and IL-1β, IL-6, IL-8, G-CSF, GM-CSF, 
IFN-γ and TNF-α are known as the proinﬂamma-
tory cytokines.  Cytokines such as IL-1β, IL-6, 
G-CSF and GM-CSF inhibit healthy human circu-
lating neutrophil apoptosis in vitro20,24,29–31, with 
G-CSF exerting the strongest effect on reducing 
Fas-induced neutrophils32.  Signiﬁcant reductions 
in Fas-induced apoptosis are not observed with 
GM-CSF, IFN-γ and TNF-α22.  The life span and 
functional activity of mature neutrophils can be 
extended in vitro by incubation with either the 
proinﬂammatory cytokines (including IL-1β, IL-6, 
G-CSF, GM-CSF, IFN-γ and TNF-α) or IL-220,30. 
In the present study, the concentrations of IL-1β 
and TNF-α in EX1 were signiﬁcantly higher than 
in EX5, indicating that inflammation was 
enhanced by EX1.
 Interleukin-10 (IL-10) counteracts the inhibition 
of neutrophil apoptosis induced by LPS, recombi-
nant human (rh) TNF-α, rhIFN-γ, rhG-CSF and 
rhGM-CSF, and also suppresses the generation of 
tissue-destructive free radical superoxide by neu-
trophils33–37.  These reports identiﬁed proinﬂam-
matory cytokines and IL-10 as strong regulators 
of spontaneous neutrophil apoptosis.  However, no 
previous report has examined the effects of cytok-
ines in exudates and thus we focused on the 
effects of IL-10 in exudates on neutrophil apopto-
sis.  In this study, anti-IL-10 antibody inhibited 
apoptosis of neutrophils incubated with EX5, indi-
cating that IL-10 is closely related to neutrophil 
apoptosis at the local site.  In vivo, various factors 
may subtly control neutrophil apoptosis by intri-
cate mechanisms at the local site after surgery. 
The prolonged survival and enhanced function of 
neutrophils incubated with exudates, via the inhi-
bition of apoptosis, may contribute to their accu-
mulation and bacterial killing at the local site. 
Although life span prolongation and the activation 
of circulating neutrophils may potentially induce 
remote organ injury, it is reasonable to consider 
that the modulation of apoptosis and the func-
tional longevity of neutrophils may be a promising 
strategy to prevent infectious complications at the 
local site in severely stressed surgical patients. 
Further studies are needed to develop procedures 
to effectively modulate the functional life span of 
neutrophils.
 In summary, we demonstrated that incubation 
of neutrophils with exudates from early inﬂamma-
tion led to augmented functions and inhibition of 
apoptosis, while neutrophils incubated with exu-
dates from late inﬂammation were induced to 
apoptosis, with IL-10 modulating neutrophil apop-
tosis.  Understanding the mechanisms of neutro-
phil apoptosis and their pathophysiologic signiﬁ-
cance at local inﬂammatory sites in vivo may help 
in the design of more effective treatments, and 
IL-10 may be a key factor in this process.
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